---

Efficacy of flupirtine maleate as pre-emptive analgesic

Full Text PDF

---

Original Article

Author Details : Lakshmi Priya, Dinesh Govindarao*, Vinay M S

Volume : 6, Issue : 3, Year : 2019

Article Page : 391-394

https://doi.org/10.18231/j.ijca.2019.075

Suggest article by email

Get Permission

Abstract

Introduction and Aim: Post-surgical pain treated with NSAIDs and opioids is associated with many adverse effects and poor patient satisfaction. Our aim was to study the effect of oral Flupirtine (200mg), as a pre-emptive analgesic in maxillo-facial surgeries.
Materials and Methods: A total of 60 patients between 18-60 years, ASA I and II, scheduled for maxillo-facial surgeries were randomised to receive orally Flupirtine maleate capsule (200mg) or Vitamin B complex capsule 2 hrs prior to surgery under general anaesthesia. The severity grading of post operative pain and time taken for first analgesic dose requirement in the post operative period was measured using Visual Analogue Score (VAS) as the primary outcome. Sedation and adverse effects of Flupirtine, if any were studied as the secondary outcome.
Results: Significant delay in demand for first postoperative analgesic dose was observed in the Flupirtine group. After the first four hours of postoperative period, we did not observe any difference in the analgesic demand between the two study groups. There was no significant sedation or adverse effects in the Flupirtine group. In addition, it was observed that hemodynamic response to intubation was significantly attenuated in the Flupirtine group.
Conclusion: Oral Flupirtine maleate is a good pre-emptive analgesic devoid of any side-effects in maxillo-facial surgeries with significant attenuation of intubation response.

Keywords:  Flupirtine maleate, Maxillo-facial surgeries, Pre-emptive analgesia, Intubation response.

How to cite : Priya L, Govindarao D , Vinay M S, Efficacy of flupirtine maleate as pre-emptive analgesic. Indian J Clin Anaesth 2019;6(3):391-394

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.